Not Yet Classified

This recall has not yet been classified by risk level.

Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Date: December 18, 2025
Company: MiramarLab, of Doral, Florida
Status: Ongoing
Source: CPSC

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed. Options: Repair

Affected Products

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Why Was This Recalled?

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Where Was This Sold?

Distribution information not available.

About MiramarLab, of Doral, Florida

MiramarLab, of Doral, Florida has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the CPSC. Last updated March 26, 2026. View original report